Ohkubo Masayuki, Nagino Masato, Kamiya Junichi, Arai Toshiyuki, Nishio Hideki, Nimura Yuji
Division of Surgical Oncology, Department of Surgery, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, 466-8550, Nagoya, Japan.
J Hepatobiliary Pancreat Surg. 2004;11(5):338-41. doi: 10.1007/s00534-004-0905-8.
Portal vein embolization can be performed safely, and so far no major complications have been reported. We report an extremely rare complication of portal vein embolization, a case of portal and mesenteric thrombosis in a 65-year-old patient with protein S deficiency. Right portal vein embolization was carried out prior to extended right hepatectomy for advanced gallbladder carcinoma involving the hepatic hilus. Computed tomography 14 days after embolization revealed massive thrombosis of the portal and the superior mesenteric veins. A protein S deficiency was found by means of an extensive workup for hypercoagulable state. Portal vein embolization may have triggered a cascade of events that was expressed as portal and mesenteric vein thrombosis resulting from deficiency of protein S. It may be better to determine the concentrations of such coagulation regulators prior to portal vein embolization.
门静脉栓塞术可以安全地进行,迄今为止尚未报告有重大并发症。我们报告一例极其罕见的门静脉栓塞并发症,一名65岁蛋白S缺乏患者发生门静脉和肠系膜血栓形成。对于累及肝门的晚期胆囊癌患者,在扩大右肝切除术前进行了右门静脉栓塞。栓塞后14天的计算机断层扫描显示门静脉和肠系膜上静脉大量血栓形成。通过对高凝状态的广泛检查发现了蛋白S缺乏。门静脉栓塞可能引发了一系列事件,表现为因蛋白S缺乏导致的门静脉和肠系膜静脉血栓形成。在门静脉栓塞术前测定此类凝血调节因子的浓度可能更好。